2018年4月12日上午，易特科（前海安测）董事长兼CEO张贯京先生，首席科学家、2014年诺贝尔医学奖得主Edvard Moser 教授，董事兼旅美科学家协会理事长宋云明博士，董事董长胜先生、副总裁兼总工程师高伟明博士、副总裁张秀萍女士、投资总监何振湘先生等一行多人到访深圳市坪山区委区政府，受到了坪山区委书记吕玉印，区委副书记、区政府区长陶永欣，区政府副区长陈华平等领导的亲切会见。
易特科（前海安测）董事长兼CEO张贯京先生和首席科学家、2014年诺贝尔医学奖得主Edvard Moser 教授围绕在坪山区共建智慧医疗诺奖实验室的工作进展做了详细汇报。张贯京先生表示，易特科（前海安测）已于近日与Edvard Moser 教授正式签署战略合作协议，携手在深圳坪山共建智慧医疗诺奖实验室，非常感谢坪山区给予的支持与指导。接下来，将共同致力于老年痴呆症（阿尔茨海默病）的预防、干预等国际前沿的生物医学、心理评估、VR病理呈现与追踪等技术研究和疾病指标的日常监测、中西医干预等方面产品开发和服务设计，在深圳打造“智慧医疗+智慧健康+智慧养老+AI” 技术创新中心与产业服务中心。
Edvard Moser 教授也表示，智慧医疗诺奖实验室，是他的团队在除挪威之外，全球第一个实验室，此次携手易特科集团（前海安测），将实验室落户深圳坪山区，相信凭借双方团队在大脑研究和疾病监测方面强大的研发实力和创新经验，凭借深圳坪山浓厚的科技研发氛围，良好的生物科技资源，包括公共平台、基础设施建设和政策支持等，一定会在阿尔兹海默病等脑神经紊乱疾病方面，取得突破性进展，为中国的大健康产业和公共卫生，为人类战胜目前最为严峻的脑神经紊乱疾病做出重要贡献。Edvard Moser教授表示，易特科集团（前海安测）在智慧医疗领域拥有3000多项专利，在中国排名第一、全球排名第四，是理想的合作伙伴，而他本人在脑科学方面的研究成果获得了诺贝尔医学奖，希望通过诺奖实验室在坪山区研发创新出世界上独一无二的阿尔兹海病的检测、预防和干预方案，让坪山区和深圳走在世界细分市场和科研领域的前沿。
On the morning of April 12, 2018, Chairman and CEO of E-Techco (Qianhai AnyCheck) Mr. Zhang Guanjing, Chief Scientist and 2014 Nobel Prize in Medicine Prof. Edvard Moser, Director of the Association of American Scientists Dr. Song Yunming, and Director Dong Changsheng Vice President and Chief Engineer Mr. Gao Weiming, Vice President Ms. Zhang Xiuping, Vice President, and the Investment Director Mr. He Zhenxiang, visited Pingshan District Party Committee of Shenzhen Municipal Government. They met with Pingshan District Party Committee Secretary Lyu Yuyin, deputy secretary of the District Party Committee, and district government chief. Tao Yongxin and the deputy head of the district government Chen Huaping.
Pingshan District Party Committee Secretary Lyu Yuyin said that Pingshan, as one of the important industrial towns in eastern Shenzhen and one of the most promising urban areas, is to build Pingshan High-tech Zone integrating R&D and production, and accelerating the creation of new energy, bio-pharmaceuticals, and a new generation of information technology. Billion-level industrial clusters, strive to achieve leapfrog development. They warmly welcome high-tech enterprises, high-end talents, and innovative projects to settle in Pingshan. Pingshan District will take the planning and construction of Pingshan High-tech Zone as the traction, and focus on the industrial deployment innovation chain to provide high-end element support for the development of the real economy.
Mr. Zhang Guanjing, chairman and CEO of E-Techco (Qianhai AnyCheck), and the chief scientist and winner of the 2014 Nobel Prize in Medicine, Professor Edvard Moser, gave a detailed report on the progress of the joint establishment of the Smart Healthcare Nobel Laboratories. Mr. Zhang Guanjing said that E-Techco (Qianhai AnyCheck) has officially signed a strategic cooperation agreement with Prof. Edvard Moser to jointly establish the Smart Medical Nobel Laboratories in Pingshan, Shenzhen. He is very grateful to Pingshan District for its support and guidance. Next, we will work together on the international frontiers of Alzheimer's disease prevention, intervention, and other international biomedical research, psychological assessment, VR pathology presentation and tracking and other technical studies and routine monitoring of disease indicators, interventions by Chinese and Western medicine, etc. In terms of product development and service design, we have established the “Smart Healthcare + Smart Health + Smart Pension + AI” Technology Innovation Center and Industrial Service Center in Shenzhen.
Prof. Edvard Moser also stated that the Smart Healthcare Nobel Laboratories is the first laboratory in the world outside of Norway. His team has teamed up with Qianhai AnyCheck to set up the laboratory in Shenzhen Pingshan District, Shenzhen. Strong research and development strengths and innovative experience in brain research and disease monitoring, with a strong R&D atmosphere in Pingshan, Shenzhen, and good bio-tech resources, including public platforms, infrastructure construction, and policy support, will surely lead to Alzheimer's disease, etc. In the area of brain disorders, breakthroughs have been made. This has made important contributions to China's great health industry and public health, and to mankind overcoming the most severe brain disorder.
There were other leaders presenting the meeting, they were Shang Haotao, executive deputy director of Pingshan District Committee Office, Su Yangdong, deputy director of the Organization Department of the District Committee, and director of the District Planning Office; Yu Yangang, Director of Shenzhen Municipal Bureau of Health and Family Planning; and Shenzhen Municipal Director of Technology Innovation Service. Xia Lei and Yao Songxing, Director of the Pingshan Management Bureau of Shenzhen Planning and Land Commission.
E-Techco group (Shenzhen E-Techco Information Technology Co., Ltd.) registered capital of 1 billion yuan. And E-Techco Group (Qianhai AnyCheck) is a High-Tech enterprise with 15 years R&D and service background, which focuses on Internet & medical & health & geriatric service, and it is in the domestic and overseas leading level of biosensor, life searching and positioning, medical informatization, health management, chronic diseases prevention, TCM preventive medicine technology provider and service practitioner. The company HQ is located in Shenzhen, with branches based in Guangzhou, Beijing, Tianjin, Xian, Shijiazhuang, Fuzhou, Shanghai, Hong Kong, with overseas institutes in north Ireland, American Silicon Valley, Toronto and so on. The number of health management centers owned and operated by E-Techco increased to nearly 90. It has more than 650 grade-2&class-A hospitals, grade 3&class 1 hospitals, and all levels health and medical institutions. The national market have been fully opened, intelligent self-help integrated machine, internet & chronic disease management, internet & emergency, internet & TCM, cloud HIS and other medical informatization products have been widely acclaimed by customers. Its business expanded to Canada, America, EU and other countries and regions. In 2017, the total annual revenue of etek group exceeded 1.6 billion RMB.
In recent years, through cooperation with famous universities and research institutes at home and abroad, E-Techco (Qianhai AnyCheck) introduced the top level talent teams at home and abroad, and continued to carry out continuous innovative exploration and industrial application in the field of artificial intelligence and intelligent medical treatment. Independent research and development of TCM Constitution identification instrument, disease prevention and service system of products and services, is a combination of traditional Chinese medicine theory and information technology with artificial intelligence technology, the application in the field of Chinese medicine, Chinese medicine to improve the digital information and intelligent level has made a major breakthrough innovation, which has been fully recognized by the State Administration of traditional Chinese medicine, China Academy of traditional Chinese medicine, Chinese Medicine Institute and many other leaders and experts. In addition, E-techco Group R & D team will artificial intelligence combined with health care, using conditional random fields (CRF), recurrent neural network (RNN), convolutional neural network (CNN) and other deep learning algorithms, to solve the Natural Language Processing (NLP) of the named entity recognition, modification, text classification problems. To construct the medical knowledge map, combined with the related decision algorithm and model applied to clinical data center (CDR), electronic medical records system (EMR), clinical information system (CIS), health management system (PEIS), the clinical decision support (CDSS), medical record retrieval and analysis (CP), mining and application medical data (DATA MINING), Such innovative applications are leading the way across the country and even around the world.